Source: International Congress 2018 – Respiratory muscles and lung function: from healthy subjects to patients
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Flynn (Los Angeles, CA, United States of America), R. Buhr (Los Angeles, CA, United States of America), X. Wang (Los Angeles, CA, United States of America), W. Lemaster (Los Angeles, CA, United States of America), B. Dolezal (Los Angeles, CA, United States of America), D. Couper (Chapel Hill, NC, United States of America), W. Anderson (Chapel Hill, NC, United States of America), R. Kanner (Salt Lake City, UT , United States of America), R. Paine (Salt Lake City, UT , United States of America), R. Kaner (New York, NY, United States of America), J. Curtis (Ann Arbor, MI, United States of America), W. O'Neal (Chapel Hill, NC, United States of America), P. Woodruff (San Francisc, United States of America), L. Postow (Bethesda, MD, United States of America), M. Han (Ann Arbor, MI, United States of America), F. Martinez (New York, NY, United States of America), G. Barr (New York, NY, United States of America), J. Wells (Birmingham, AL, United States of America), V. Ortega (Winston-Salem, NC, United States of America), S. Peters (Winston-Salem, NC, United States of America), E. Hoffman (Iowa City, IA , United States of America), C. Doerschuk (Chapel Hill, NC, United States of America), V. Kim (Philadelphia, PA, United States of America), M. Dransfield (Birmingham, AL, United States of America), S. Bhatt (Birmingham, AL, United States of America), N. Bhakta (San Francisco, CA, United States of America), B. Drummond (Chapel Hill, NC, United States of America), R. Bowler (Denver, CO, United States of America), G. Criner (Philadelphia, PA, United States of America), C. Pirozzi (Salt Lake City, UT, United States of America), C. Martinez (Ann Arbor, MI, United States of America), C. Cooper (Los Angeles, CA, United States of America), I. Barjaktarevic (Los Angeles, CA, United States of America). Reduced FEV3/FVC identifies smokers at risk of developing COPD in the SPIROMICS cohort. 2152

Member's Comments

No comment yet.

Related content which might interest you: High prevalence of undiagnosed COPD in a cohort of HIV-infected smokers Source: Eur Respir J 2015; 45: 828-831 Year: 2015 Lymphopenia is linked to an increased incidence of cancer in smokers without COPD Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Biomarkers to predict FEV1 decline in smokers and early-onset COPD. Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2020 Quantification of smokers and smoking status among COPD patients, hospitalized for an exacerbation Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011 Newly developed simple QoL questionnaire in early detection of COPD in a population of smokers at risk for COPD development Source: Annual Congress 2012 - Methodology in epidemiologic research Year: 2012 Prevalence characteristics of COPD in never smokers Source: Annual Congress 2012 - COPD epidemiology Year: 2012 Prevalence characteristics of COPD in never smokers Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012 Risk of COPD in smokers with low transfer factor Source: Eur Respir J 2016; 47:1885-1886 Year: 2016 COPD hospitalizations in never smokers: comparison with current smokers Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Identifying the at risk smokers: who goes on to get COPD? Source: Eur Respir J, 54 (4) 1901613; 10.1183/13993003.01613-2019 Year: 2019 Co-morbidities of adult smokers at risk of COPD evaluated in a 6-year prospective study Source: International Congress 2015 – COPD: notable points Year: 2015 COPD and lung cancer incidence in never smokers Source: International Congress 2019 – Asthma and COPD comorbidities Year: 2019 Will the population ²at risk for COPD² develop COPD? Source: Eur Respir J 2005; 26: Suppl. 49, 218s Year: 2005 Comorbidities by smokers with COPD and influence of risk factors Source: Annual Congress 2010 - Smoking related disorders Year: 2010 Mortality risks of COPD for nonsmokers and smokers from a prospective cohort study of 390,269 subjects in Taiwan – Assessing involvement beyond the lungs Source: Annual Congress 2012 - COPD epidemiology Year: 2012 The utility of echocardiography in elderly smokers with COPD and of spirometry in elderly smokers with CHF Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Current asthma is associated with increased exhaled NO levels in never smokers from a population-based study Source: Eur Respir J 2007; 30: Suppl. 51, 625s Year: 2007 Metabolomics identifies biomarkers of exacerbations in smokers with and without COPD Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases Year: 2020 Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020 Year: 2021 Tobacco smoking is associated with higher risk for COPD in women than in men Source: Eur Respir J 2002; 20: Suppl. 38, 514s Year: 2002